Website governance · working draft
Website access is not a product contract.
These draft terms are intentionally limited to the public website. They do not grant PHARMORIS access, create a customer deployment or replace a negotiated commercial agreement.
01 · Website use
Information and exploration, not an offer to supply.
The public website provides general information about NEUVIOR Pharmaceuticals Ltd, its current positioning, public records and the controlled development of PHARMORIS.
Website content, an enquiry response, a representative demonstration or access to a public document does not by itself create a customer relationship, licence, deployment commitment, procurement acceptance, assurance approval or promise of a particular outcome.
A product evaluation or future service would require a separate written agreement that defines scope, responsibilities, data roles, security requirements, charges, support and acceptance conditions.
Permitted use
Visitors may view and reference the website for lawful personal or organisational evaluation, subject to intellectual property rights.
Public accessProhibited use
Do not misuse the site, attempt unauthorised access, interfere with operation, submit malicious content or misrepresent NEUVIOR material.
Security boundaryEnquiry content
Do not send information that identifies a patient, confidential clinical records, credentials, access tokens or content you have no right to disclose.
Submission boundary02 · Content and evidence
Current status and future intent must stay separate.
NEUVIOR aims to keep public information accurate and clearly sourced, but website material is provided for general information and may change as evidence, product development or company circumstances change.
Nothing on this website is clinical, prescribing, legal, financial, investment, procurement or regulatory advice. Authorised professionals and institutions remain responsible for their own decisions and assurance.
PHARMORIS is a supplier candidate under controlled development and is not in production. It is not presented as ready for NHS deployment today. Representative diagrams and demonstrations are not live unless a page expressly provides verified evidence to the contrary.
Public records
External public records remain subject to the terms and accuracy of their issuing organisations.
Led by sourcesExternal links
A link is provided for context and does not by itself constitute endorsement, control or continuing availability.
Independent destinationsAvailability
The website may be changed, suspended or unavailable. This draft does not promise uninterrupted operation or operation without errors.
No service commitment03 · Ownership and legal review
Brand, content and product rights remain protected.
NEUVIOR names, marks, original website content, software concepts and design elements remain protected by their applicable ownership and intellectual property rights. Public access does not transfer those rights.
Reasonable linking to a public page is permitted when it is accurate, lawful and does not imply endorsement or partnership. Republishing substantial content, using brand assets commercially or framing the site as another service requires prior written permission.
This working draft must receive formal legal review before it becomes effective. In particular, governing law, liability limitations, consumer applicability, intellectual property wording and final deployment practices require counsel approval.
Make the next step useful
Bring the problem that needs a clearer decision.
Tell us what is stuck, what decision you need to make and what a better outcome would change. We will connect you to the most relevant NEUVIOR, PHARMORIS, media or investor route.